SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Innova Captab - Quaterly Results

24 Jan 2026 Evaluate
The sales for the December 2025 quarter moved up 46.35% to Rs. 3637.27 millions as compared to Rs. 2485.25 millions during the corresponding quarter last year.The Company has registered profit of Rs. 279.01  millions for the quarter ended December 2025, a growth of 14.34%  over Rs. 244.02 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended December 2025 rose to 502.00 millions as compared to 359.85 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 3637.27 2485.25 46.35 9405.37 7155.39 31.44 9580.61 8649.29 10.77
Other Income 32.05 34.94 -8.27 121.51 124.19 -2.16 167.75 107.18 56.51
PBIDT 502.00 359.85 39.50 1232.91 1065.38 15.72 1390.74 1186.88 17.18
Interest 34.66 1.33 2506.02 114.40 2.99 3726.09 21.68 135.91 -84.05
PBDT 467.34 358.52 30.35 1118.51 1062.39 5.28 1369.06 1050.97 30.27
Depreciation 94.08 30.79 205.55 279.64 92.03 203.86 170.15 113.99 49.27
PBT 373.26 327.73 13.89 838.87 970.36 -13.55 1198.91 936.98 27.95
TAX 94.25 83.71 12.59 213.57 246.91 -13.50 304.21 255.37 19.13
Deferred Tax 18.10 20.89 -13.36 45.27 54.32 -16.66 84.21 3.53 2285.55
PAT 279.01 244.02 14.34 625.30 723.45 -13.57 894.70 681.61 31.26
Equity 572.25 572.25 0.00 572.25 572.25 0.00 572.25 572.25 0.00
PBIDTM(%) 13.80 14.48 -4.68 13.11 14.89 -11.96 14.52 13.72 5.79

Innova Captab Share Price

690.00 0.15 (0.02%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×